Removal of Mannose-Ending Glycan at Asn


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 26 11 2019
accepted: 19 02 2020
entrez: 11 4 2020
pubmed: 11 4 2020
medline: 24 3 2021
Statut: epublish

Résumé

The development of an immune response against therapeutic factor VIII is the major complication in hemophilia A patients. Oligomannose carbohydrates at N239 and/or N2118 on factor VIII allow its binding to the macrophage mannose receptor expressed on human dendritic cells, thereby leading to factor VIII endocytosis and presentation to CD4+ T lymphocytes. Here, we investigated whether altering the interaction of factor VIII with mannose-sensitive receptors on antigen-presenting cells may be a strategy to reduce factor VIII immunogenicity. Gene transfer experiments in factor VIII-deficient mice indicated that N239Q and/or N2118Q factor VIII mutants have similar specific activities as compared to non-mutated factor VIII; N239Q/N2118Q mutant corrected blood loss upon tail clip. Production of the corresponding recombinant FVIII mutants or light chains indicated that removal of the N-linked glycosylation site at N2118 is sufficient to abrogate

Identifiants

pubmed: 32273875
doi: 10.3389/fimmu.2020.00393
pmc: PMC7117063
doi:

Substances chimiques

Lectins, C-Type 0
Mannose Receptor 0
Mannose-Binding Lectins 0
Receptors, Cell Surface 0
Factor VIII 9001-27-8
Mannose PHA4727WTP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

393

Informations de copyright

Copyright © 2020 Delignat, Rayes, Dasgupta, Gangadharan, Denis, Christophe, Bayry, Kaveri and Lacroix-Desmazes.

Références

Nat Genet. 1995 May;10(1):119-21
pubmed: 7647782
Blood. 2010 Feb 4;115(5):1081-7
pubmed: 20007547
J Thromb Haemost. 2018 Jun 11;:
pubmed: 29888865
Front Immunol. 2014 Aug 25;5:404
pubmed: 25202310
Blood. 2003 Feb 15;101(4):1351-8
pubmed: 12393451
Haematologica. 2019 Feb;104(2):236-244
pubmed: 30514798
Blood. 2008 Jul 15;112(2):240-9
pubmed: 18469198
Mol Cell Proteomics. 2011 Jun;10(6):M110.002246
pubmed: 21467215
Haematologica. 2017 Feb;102(2):271-281
pubmed: 27758819
J Exp Med. 1999 Jun 21;189(12):1961-72
pubmed: 10377192
Lancet. 1992 Jul 25;340(8813):253
pubmed: 1353186
J Immunol. 2006 Jun 1;176(11):6770-6
pubmed: 16709836
J Immunol. 2007 May 15;178(10):6259-67
pubmed: 17475854
Blood. 2010 Apr 1;115(13):2682-5
pubmed: 19890094
Immunology. 2008 Mar;123(3):438-46
pubmed: 17944899
Blood. 1998 Nov 15;92(10):3701-9
pubmed: 9808564
Anal Chem. 1997 Oct 1;69(19):3986-94
pubmed: 9322435
Blood. 2013 Feb 21;121(8):1446-54
pubmed: 23223434
J Immunol Methods. 1999 Feb 1;223(1):77-92
pubmed: 10037236
Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):419-24
pubmed: 18187670
J Clin Invest. 2015 Oct 1;125(10):3766-81
pubmed: 26426076
J Thromb Haemost. 2009 Dec;7(12):2006-2015
pubmed: 19817985
Eur J Immunol. 2004 Nov;34(11):3060-9
pubmed: 15468058
PLoS One. 2012;7(10):e46959
pubmed: 23071675
Annu Rev Immunol. 2004;22:33-54
pubmed: 15032573
J Thromb Haemost. 2010 Oct;8(10):2338-40
pubmed: 20704649
Haemophilia. 2012 Mar;18(2):248-54
pubmed: 22044692
Blood. 2012 May 31;119(22):5294-300
pubmed: 22498747
J Thromb Haemost. 2003 Nov;1(11):2360-7
pubmed: 14629470
J Thromb Haemost. 2009 Nov;7(11):1816-23
pubmed: 19682235
J Biol Chem. 1996 Nov 1;271(44):27424-31
pubmed: 8910322
J Leukoc Biol. 2012 Dec;92(6):1177-86
pubmed: 22966131
Lab Invest. 2005 Oct;85(10):1238-49
pubmed: 16056240
J Allergy Clin Immunol. 2012 Feb;129(2):501-9, 509.e1-5
pubmed: 21962992
J Thromb Haemost. 2019 Apr;17(4):681-694
pubmed: 30740857
Haemophilia. 2014 Jul;20(4):486-92
pubmed: 24372710
Arterioscler Thromb Vasc Biol. 2016 May;36(5):855-63
pubmed: 27013611
J Allergy Clin Immunol. 2012 Apr;129(4):1172-3; author reply 1174-5
pubmed: 22336079
Int J Mol Sci. 2012;13(8):10113-31
pubmed: 22949850
Biochem J. 2018 Mar 6;475(5):873-886
pubmed: 29444815
Blood. 2007 Jan 15;109(2):610-2
pubmed: 16985172
Blood. 1998 Jul 15;92(2):496-506
pubmed: 9657749
PLoS One. 2013;8(1):e52875
pubmed: 23341914
J Thromb Haemost. 2011 Apr;9(4):689-99
pubmed: 21251204
Proc Natl Acad Sci U S A. 2007 May 22;104(21):8965-70
pubmed: 17502612
Thromb Res. 2013 Jan;131(1):78-88
pubmed: 23058466
Biochem J. 1991 Jul 1;277 ( Pt 1):23-31
pubmed: 1906711
Protein Eng. 1988 Oct;2(4):301-6
pubmed: 3150544
Science. 2002 Mar 8;295(5561):1898-901
pubmed: 11884756

Auteurs

Sandrine Delignat (S)

Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France.

Julie Rayes (J)

Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France.

Suryasarathi Dasgupta (S)

Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France.

Bagirath Gangadharan (B)

Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France.

Cécile V Denis (CV)

HITh, UMR_S1176, INSERM, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

Olivier D Christophe (OD)

HITh, UMR_S1176, INSERM, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

Jagadeesh Bayry (J)

Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France.

Srinivas V Kaveri (SV)

Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France.

Sébastien Lacroix-Desmazes (S)

Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH